Literature DB >> 16401372

Validation of prostate cancer index and SF-12 short forms.

Thierry Lebeau1, Paul Perrotte, Luc Valiquette, François Bénard, Michael McCormack, Fred Saad, Pierre I Karakiewicz.   

Abstract

BACKGROUND: Assessment of prostate cancer (PCa) specific and generic health-related quality-of-life (HRQOL) is frequently omitted due to several obstacles, such as respondent burden and infrastructure-related limitations. We attempted to reduce the number of items of two commonly used HRQOL assessment tools, namely the UCLA PCa Index (PCI) and the RAND SF-12, with the intent of generating the most parsimonious, yet psychometrically valid and reliable HRQOL assessment tool.
METHODS: The PCI and SF-12 were administered to 2415 radical prostatectomy patients, and re-tested in a convenience sample of 35 men with PCa. Multivariate linear regression models defined the most predictive and item-reduced SF-12 and PCI item combinations. These were subjected to standard psychometric reliability and validity tests.
RESULTS: The 8-item PCI sexual function (SF) scale was reduced to three items. The 5-item PCI urinary function (UF) scale was reduced to three items. The 6-item SF-12 mental health scale was reduced to three items, and the 6-item SF-12 physical scale was also reduced to three items. The total number of items was reduced from 27 to 12 (44%). The item-reduced scales accounted for over 85% of full-scale variance. All reliability and validity tests yielded highly satisfactory results.
CONCLUSION: We developed SF-12 and PCI short-forms, which consist of 12 of 27 (44%) original items and can be completed by most men within 2 minutes. The short-forms represent a valid substitute for the full scales, as they provide over 85% of full-scale information and demonstrate excellent reliability statistics. The short forms have the potential for decreasing respondent burden and infrastructure-related requirements, which may in turn promote HRQOL assessment after radical prostatectomy.

Entities:  

Mesh:

Year:  2005        PMID: 16401372

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  3 in total

1.  Long-term outcomes in pediatric-onset esophageal eosinophilia.

Authors:  Charles W DeBrosse; James P Franciosi; Eileen C King; Bridget K Buckmeier Butz; Allison B Greenberg; Margaret H Collins; J Pablo Abonia; Amal Assa'ad; Philip E Putnam; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2011-06-02       Impact factor: 10.793

2.  The Barretos short instrument for assessment of quality of life (BSIqol): development and preliminary validation in a cohort of cancer patients undergoing antineoplastic treatment.

Authors:  Carlos Eduardo Paiva; Fernanda Capella Rugno; Bianca Sakamoto Ribeiro Paiva
Journal:  Health Qual Life Outcomes       Date:  2012-11-29       Impact factor: 3.186

3.  A pilot study of patient reported outcomes evaluating treatment related symptoms and quality of life for men receiving high dose rate brachytherapy combined with hypo-fractionated radiotherapy or hypo-fractionated radiotherapy alone for the treatment of localised prostate cancer.

Authors:  Karen Crowther; Aidan Cole; Pat Shiels; Suneil Jain; Paul Shepherd; Darren Mitchell
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2019-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.